Carbapenemases: the Versatile β-Lactamases

By A. Queenan, K. Bush. Clinical Microbiology Reviews, 2007

2,242 citations recorded by the source corpus.

Subfields: Endocrinology, Food Science, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/8560acca0b13fce4e8cae18e51ee6ab446693149

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology

1. P. Nordmann
2. L. Poirel
3. J. Pitout
4. F. Codjoe
5. E. Donkor
6. L. Logan
7. Robert A. Weinstein
8. Amy Mathers

In Food Science

1. F. Codjoe
2. E. Donkor
3. T. Naas
4. H. Nikaido
5. A. Carattoli
6. P. Nordmann
7. L. Poirel

In Molecular Medicine

1. P. Nordmann
2. L. Poirel
3. J. Pitout
4. F. Codjoe
5. E. Donkor
6. Robert A. Weinstein
7. L. Logan
8. T. Naas

Citations in the corpus

• Global Spread of Carbapenemase-producing Enterobacteriaceae (2011, background): “Since then, a large variety of carbapenemases has been identifi ed in Enterobacteriaceae belonging to 3 classes of β-lactamases: the Ambler class A, B, and D β-lactamases (2).”
• Antibiotic resistance and persistence—Implications for human health and treatment perspectives (2020, neutral): “Together with the increasing numbers of bacteria carrying ESBL genes, the use of carbapenems has increased in the last two decades leading to the emergence of carbapenemase-producing strains (Queenan & Bush, 2007).”
• Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. (2015, background): “aeruginosa in Japan and is now globally distributed, suggesting horizontal transfer of blaIMP-1 between unrelated Gram-negative species [145].”
• The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (2015, background): “Klebsiella pneumoniae Carbapenemase) (25) (for a summary on which Enterobacteriaceae produce these enzymes, the classification, spectrum of activity, inhibition properties, types, endemic regions and molecular epidemiology of KPCs, please refer to Table 1).”
• Carbapenems: Past, Present, and Future (2011, background): “9 Production of β-lactamases appears to be the most widespread cause of carbapenem resistance as 10 the documentation of their distribution in different bacterial species is extensive (189, 242, 243).”
• Three Decades of β-Lactamase Inhibitors (2010, neutral): “sporins, penicillins, and aztreonam (356).”
• Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. (2011, background): “carbapenemase (KPC), an Ambler molecular class A enzyme that utilizes serine at the active site to facilitate hydrolysis of a broad variety of b-lactams [14].”
• Carbapenem Resistance: A Review (2017, background): “The genes encoding these enzymes are often located within a variety of integron structures and incorporated in to the gene cassettes [37,74].”
• The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace (2017, background): “there were several reports of VIM-type MBLs in Enterobacteriaceae [13].”
• Acquired Antibiotic Resistance Genes: An Overview (2011, background): “…expressing β-lactamases, for example extended-spectrum β-lactamases (ESBLs), plasmid-mediated AmpC enzymes, and carbapenem-hydrolyzing β-lactamases (carbapenemases; Bradford, 2001; Jacoby and Munoz-Price, 2005; Paterson and Bonomo, 2005; Poirel et al., 2007; Queenan and Bush, 2007; Jacoby, 2009).”